Clinical lymphoma, myeloma & leukemia
Journal
Overview
publication venue for
-
Hepatosplenic T-Cell Lymphoma Mimicking Acute Myeloid Leukemia.
2015
-
BRAF V600E mutation and clonal evolution in a patient with relapsed refractory myeloma with plasmablastic differentiation.
2013
-
Safety and Toxicity Profiles of CAR T Cell Therapy in Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis.
2024
-
Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial.
2024
-
Treatment Discontinuation Patterns for Patients With Chronic Lymphocytic Leukemia in Real-World Settings: Results From a Multi-Center International Study.
2023
-
Age Differences in Clinical Trial Understanding in Non-Hodgkin Lymphoma Patients..
22.
2022
-
Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience.
2021
-
Acute Myeloid Leukemia Patients Requiring Two Cycles of Intensive Induction for Attainment of Remission Experience Inferior Survival Compared with Patients Requiring a Single Course of Induction Chemotherapy..
22.
2021
-
Worsening Quality of Life in Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients in Active Surveillance: A 12-Month Longitudinal Study..
22.
2021
-
An Assessment of Race as a Risk Factor for Doxorubicin-Related Cardiotoxicity in Diffuse Large B-Cell Lymphoma..
22.
2021
-
Multiple Myeloma in Hispanics: Incidence, Characteristics, Survival, Results of Discovery, and Validation Using Real-World and Connect MM Registry Data..
21.
2020
-
Burkitt Lymphoma - Subtypes, Pathogenesis, and Treatment Strategies..
20 Suppl 1.
2020
-
Impact of Insurance Status on Survival Outcomes in Adults With Acute Lymphoblastic Leukemia (ALL): A Single-center Experience..
20.
2020
-
Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities..
20.
2020
-
Lymphoma Study Titles on ClinicalTrials.gov Lack Details Necessary for Study Identification..
20.
2019
-
Oprozomib, pomalidomide, and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma..
19.
2019
-
Carfilzomib-Dexamethasone Versus Bortezomib-Dexamethasone in Relapsed or Refractory Multiple Myeloma: Updated Overall Survival, Safety, and Subgroups..
19.
2019
-
Phase 2 Study of Iodine-131 Tositumomab Plus Chemotherapy in Patients With Previously Untreated Mantle-Cell Lymphoma..
20.
2019
-
Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell Lymphoma..
19.
2019
-
Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin Lymphomas..
19.
2018
-
A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma..
18.
2018
-
Clinical Outcomes With Ring Sideroblasts and SF3B1 Mutations in Myelodysplastic Syndromes: MDS Clinical Research Consortium Analysis..
18.
2018
-
Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075)..
18.
2018
-
Cellular Proliferation by Multiplex Immunohistochemistry Identifies High-Risk Multiple Myeloma in Newly Diagnosed, Treatment-Naive Patients..
17.
2017
-
Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States..
17.
2017
-
Cross-Intolerance With Dasatinib Among Imatinib-Intolerant Patients With Chronic Phase Chronic Myeloid Leukemia..
16.
2016
-
Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful Engraftment..
16.
2016
-
Evaluating the Impact of a Switch to Nilotinib on Imatinib-Related Chronic Low-Grade Adverse Events in Patients With CML-CP: The ENRICH Study..
16.
2016
-
CHOP Chemotherapy Followed by Tositumomab and Iodine-131 Tositumomab for Previously Untreated Diffuse Large B-cell Lymphoma..
16.
2016
-
Role of Surveillance Imaging in Patients With Peripheral T-Cell Lymphoma..
16.
2015
-
Trends and Disparities in Cardiovascular Mortality Among Survivors of Hodgkin Lymphoma..
15.
2015
-
Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: an open label, single arm, phase II trial..
15.
2014
-
Quantitative measures of physical functioning after autologous hematopoietic stem cell transplantation in multiple myeloma: a feasibility study..
15.
2014
-
Feasibility and efficacy of local radiotherapy with concurrent novel agents in patients with multiple myeloma..
14.
2014
-
Long-term follow-up of R-CHOP with bevacizumab as initial therapy for mantle cell lymphoma: clinical and correlative results..
14.
2013
-
A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remission..
13.
2013
-
Successful long-term treatment of Philadelphia chromosome-negative myeloproliferative neoplasms with combination of hydroxyurea and anagrelide..
13 Suppl 2.
2013
-
Outcomes in patients with relapsed or refractory acute promyelocytic leukemia treated with or without autologous or allogeneic hematopoietic stem cell transplantation..
13.
2013
-
Comparative response assessment by serum immunoglobulin M M-protein and total serum immunoglobulin M after treatment of patients with Waldenström macroglobulinemia..
13.
2013
-
Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections..
13.
2012
-
Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience..
13.
2012
-
Current practices in the management of chronic myeloid leukemia..
13.
2012
-
Pralatrexate is an effective treatment for relapsed or refractory transformed mycosis fungoides: a subgroup efficacy analysis from the PROPEL study..
12.
2012
-
Clonal plasma cell pathophysiology and clinical features of disease are linked to clonal plasma cell expression of cyclin D1 in systemic light-chain amyloidosis..
12.
2011
-
Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations..
12.
2011
-
CD39 expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemia..
11.
2011
-
Response to second-line therapy defines the potential for cure in patients with recurrent diffuse large B-cell lymphoma: implications for the development of novel therapeutic strategies..
10.
2010
-
Real-World Efficacy Outcomes of FLT3-ITDmut Acute Myeloid Leukemia Patients Treated with Midostaurin in Combination with Intensive Induction.
2022
-
Management of Adverse Events From the Combination of Rituximab and Lenalidomide in the Treatment of Patients With Follicular and Low-Grade Non-Hodgkin Lymphoma.
2020
-
Response Kinetics and Clinical Benefits of Nonintensive AML Therapies in the Absence of Morphologic Response.
2019
-
Evidence for and Against Green Tea and Turmeric in the Management of Chronic Lymphocytic Leukemia.
2018
-
Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management.
2016
-
Ruxolitinib for myelofibrosis--an update of its clinical effects.
2013
-
Pitfalls in the diagnosis of primary amyloidosis.
2010
-
Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell Lymphoma.
2016
-
Challenges with serum protein electrophoresis in assessing progression and clinical response in patients with Waldenström macroglobulinemia.
2013
-
Management of mantle cell lymphoma: key challenges and next steps.
2010
Identity
ISO Abbreviation
-
Clin Lymphoma Myeloma Leuk
Linking ISSN
Electronic International Standard Serial Number (EISSN)